methodological framework and tools for cross …users.ugent.be/~lvbortel/sunday_10.pdfdefinition of...
TRANSCRIPT
![Page 1: Methodological Framework and Tools for Cross …users.ugent.be/~lvbortel/Sunday_10.pdfDefinition of drug utilization research and deliniation ... Pharmacoeconomics. ... Introduction](https://reader031.vdocuments.us/reader031/viewer/2022030423/5aaab43b7f8b9a9a188e9069/html5/thumbnails/1.jpg)
Methodological Framework and
Tools for Cross-National comparisons of
Drug Utilization Data
Vander Stichele RH, MD, PhD
Heymans Institute of Pharmacology, Ghent University, Belgium
Summer School EACPT August 24-27, 2007 Ghent University
![Page 2: Methodological Framework and Tools for Cross …users.ugent.be/~lvbortel/Sunday_10.pdfDefinition of drug utilization research and deliniation ... Pharmacoeconomics. ... Introduction](https://reader031.vdocuments.us/reader031/viewer/2022030423/5aaab43b7f8b9a9a188e9069/html5/thumbnails/2.jpg)
OVERVIEW
1. Definition of drug utilization research and deliniation from other scientific fields
2. Methodological framework for drug utilization research
3. The micro level of drug utilizationUnderstanding prescribing behavior and patient drug taking behavior
4. The macro level of drug utilization Tools for cross-national comparisons of drug utilization data
![Page 3: Methodological Framework and Tools for Cross …users.ugent.be/~lvbortel/Sunday_10.pdfDefinition of drug utilization research and deliniation ... Pharmacoeconomics. ... Introduction](https://reader031.vdocuments.us/reader031/viewer/2022030423/5aaab43b7f8b9a9a188e9069/html5/thumbnails/3.jpg)
Definitions
Epidemiology
Clinical pharmacology
Pharmaco-epidemiology
Drug utilization research
![Page 4: Methodological Framework and Tools for Cross …users.ugent.be/~lvbortel/Sunday_10.pdfDefinition of drug utilization research and deliniation ... Pharmacoeconomics. ... Introduction](https://reader031.vdocuments.us/reader031/viewer/2022030423/5aaab43b7f8b9a9a188e9069/html5/thumbnails/4.jpg)
POPULATION
DISEASE
DRUG
![Page 5: Methodological Framework and Tools for Cross …users.ugent.be/~lvbortel/Sunday_10.pdfDefinition of drug utilization research and deliniation ... Pharmacoeconomics. ... Introduction](https://reader031.vdocuments.us/reader031/viewer/2022030423/5aaab43b7f8b9a9a188e9069/html5/thumbnails/5.jpg)
POPULATION
DISEASE
DRUG
Pharmaco-epidemiology
EpidemiologyClinical pharmacology
![Page 6: Methodological Framework and Tools for Cross …users.ugent.be/~lvbortel/Sunday_10.pdfDefinition of drug utilization research and deliniation ... Pharmacoeconomics. ... Introduction](https://reader031.vdocuments.us/reader031/viewer/2022030423/5aaab43b7f8b9a9a188e9069/html5/thumbnails/6.jpg)
POPULATION
DISEASE
DRUG
Pharmaco-epidemiology
EpidemiologyClinical pharmacology
Public Health
![Page 7: Methodological Framework and Tools for Cross …users.ugent.be/~lvbortel/Sunday_10.pdfDefinition of drug utilization research and deliniation ... Pharmacoeconomics. ... Introduction](https://reader031.vdocuments.us/reader031/viewer/2022030423/5aaab43b7f8b9a9a188e9069/html5/thumbnails/7.jpg)
DEFINITIONS
Epidemiology
“the study of the distribution and determinants of health-related states and events in the population, and the application of this study to control health problems”
Clinical Pharmacology
“the study of effect of drugs in humans.”
Pharmaco-epidemiology
“the study of the utilization and effects of drugs in large numbers of people.”
![Page 8: Methodological Framework and Tools for Cross …users.ugent.be/~lvbortel/Sunday_10.pdfDefinition of drug utilization research and deliniation ... Pharmacoeconomics. ... Introduction](https://reader031.vdocuments.us/reader031/viewer/2022030423/5aaab43b7f8b9a9a188e9069/html5/thumbnails/8.jpg)
DEFINITIONS AND DELINEATION OF THE FIELDS (2/4)
Pharmaco-epidemiology (delineation of its core) • To determine the (balance between benefit and) risk
of the use of medicines using population-based databases
Related to : Pharmacovigilance
Pharmaceutical Outcomes Research
Pharmacoeconomics
Health Technology Assessment
![Page 9: Methodological Framework and Tools for Cross …users.ugent.be/~lvbortel/Sunday_10.pdfDefinition of drug utilization research and deliniation ... Pharmacoeconomics. ... Introduction](https://reader031.vdocuments.us/reader031/viewer/2022030423/5aaab43b7f8b9a9a188e9069/html5/thumbnails/9.jpg)
DEFINITION OF DRUG UTILIZATION RESEARCH
is an eclectic discipline, integrating
descriptive and analytical methods for the quantification, the understanding and the evaluation of
the processes of prescribing, dispensing and consumption of medicines
and for
the testing of interventions to enhance the quality of these processes.
Drug utilization research
![Page 10: Methodological Framework and Tools for Cross …users.ugent.be/~lvbortel/Sunday_10.pdfDefinition of drug utilization research and deliniation ... Pharmacoeconomics. ... Introduction](https://reader031.vdocuments.us/reader031/viewer/2022030423/5aaab43b7f8b9a9a188e9069/html5/thumbnails/10.jpg)
Methodological framework
![Page 11: Methodological Framework and Tools for Cross …users.ugent.be/~lvbortel/Sunday_10.pdfDefinition of drug utilization research and deliniation ... Pharmacoeconomics. ... Introduction](https://reader031.vdocuments.us/reader031/viewer/2022030423/5aaab43b7f8b9a9a188e9069/html5/thumbnails/11.jpg)
Conceptual framework for drug utilization research
Quantify Understand Evaluate
Test interventions to enhance quality
Prescribing
Dispensing
Consumption
![Page 12: Methodological Framework and Tools for Cross …users.ugent.be/~lvbortel/Sunday_10.pdfDefinition of drug utilization research and deliniation ... Pharmacoeconomics. ... Introduction](https://reader031.vdocuments.us/reader031/viewer/2022030423/5aaab43b7f8b9a9a188e9069/html5/thumbnails/12.jpg)
Conceptual framework for drug utilization research
Quantify Understand Evaluate
Test Interventions to enhance quality
Prescribing
Dispensing
Consumption
Cross National
comparisons
![Page 13: Methodological Framework and Tools for Cross …users.ugent.be/~lvbortel/Sunday_10.pdfDefinition of drug utilization research and deliniation ... Pharmacoeconomics. ... Introduction](https://reader031.vdocuments.us/reader031/viewer/2022030423/5aaab43b7f8b9a9a188e9069/html5/thumbnails/13.jpg)
Conceptual framework for drug utilization research
Quantify Understand Evaluate
Test Interventions to enhance quality
Prescribing
Dispensing
Consumption Health surveys
![Page 14: Methodological Framework and Tools for Cross …users.ugent.be/~lvbortel/Sunday_10.pdfDefinition of drug utilization research and deliniation ... Pharmacoeconomics. ... Introduction](https://reader031.vdocuments.us/reader031/viewer/2022030423/5aaab43b7f8b9a9a188e9069/html5/thumbnails/14.jpg)
Conceptual framework for drug utilization research
Quantify Understand Evaluate
Test Interventions to enhance quality
Prescribing
Dispensing
Consumption
Drug choice process
![Page 15: Methodological Framework and Tools for Cross …users.ugent.be/~lvbortel/Sunday_10.pdfDefinition of drug utilization research and deliniation ... Pharmacoeconomics. ... Introduction](https://reader031.vdocuments.us/reader031/viewer/2022030423/5aaab43b7f8b9a9a188e9069/html5/thumbnails/15.jpg)
Conceptual framework for drug utilization research
Quantify Understand Evaluate
Test Interventions to enhance quality
Prescribing
Dispensing
ConsumptionPatient compliance studies
![Page 16: Methodological Framework and Tools for Cross …users.ugent.be/~lvbortel/Sunday_10.pdfDefinition of drug utilization research and deliniation ... Pharmacoeconomics. ... Introduction](https://reader031.vdocuments.us/reader031/viewer/2022030423/5aaab43b7f8b9a9a188e9069/html5/thumbnails/16.jpg)
Conceptual framework for drug utilization research
Quantify Understand Evaluate
Test Interventions to enhance quality
Prescribing
Dispensing
Consumption
Prescribing quality indicators
![Page 17: Methodological Framework and Tools for Cross …users.ugent.be/~lvbortel/Sunday_10.pdfDefinition of drug utilization research and deliniation ... Pharmacoeconomics. ... Introduction](https://reader031.vdocuments.us/reader031/viewer/2022030423/5aaab43b7f8b9a9a188e9069/html5/thumbnails/17.jpg)
Conceptual framework for drug utilization research
Quantify Understand Evaluate
Test Interventions to enhance quality
Prescribing
Dispensing
Consumption
Individual prescription feedback
![Page 18: Methodological Framework and Tools for Cross …users.ugent.be/~lvbortel/Sunday_10.pdfDefinition of drug utilization research and deliniation ... Pharmacoeconomics. ... Introduction](https://reader031.vdocuments.us/reader031/viewer/2022030423/5aaab43b7f8b9a9a188e9069/html5/thumbnails/18.jpg)
Conceptual framework for drug utilization research
Quantify Understand Evaluate
Test Interventions to enhance quality
Prescribing
Dispensing
Consumption
Risk Manage-ment
![Page 19: Methodological Framework and Tools for Cross …users.ugent.be/~lvbortel/Sunday_10.pdfDefinition of drug utilization research and deliniation ... Pharmacoeconomics. ... Introduction](https://reader031.vdocuments.us/reader031/viewer/2022030423/5aaab43b7f8b9a9a188e9069/html5/thumbnails/19.jpg)
Conceptual framework for drug utilization research
Quantify Understand Evaluate
Test Interventions to enhance quality
Prescribing
Dispensing
Consumption Patient education
![Page 20: Methodological Framework and Tools for Cross …users.ugent.be/~lvbortel/Sunday_10.pdfDefinition of drug utilization research and deliniation ... Pharmacoeconomics. ... Introduction](https://reader031.vdocuments.us/reader031/viewer/2022030423/5aaab43b7f8b9a9a188e9069/html5/thumbnails/20.jpg)
Conceptual framework for drug utilization research
Quantify Understand Evaluate
Test Interventions to enhance quality
Prescribing
Dispensing
Consumption
Drug
policy
research
![Page 21: Methodological Framework and Tools for Cross …users.ugent.be/~lvbortel/Sunday_10.pdfDefinition of drug utilization research and deliniation ... Pharmacoeconomics. ... Introduction](https://reader031.vdocuments.us/reader031/viewer/2022030423/5aaab43b7f8b9a9a188e9069/html5/thumbnails/21.jpg)
DEFINITION OF DRUG UTILIZATION RESEARCH
is an eclectic discipline, integrating
descriptive and analytical methods for the quantification, the understanding and the evaluation of
the processes of prescribing, dispensing and consumption of medicines
and for
the testing of interventions to enhance the quality of these processes.
Drug utilization research
![Page 22: Methodological Framework and Tools for Cross …users.ugent.be/~lvbortel/Sunday_10.pdfDefinition of drug utilization research and deliniation ... Pharmacoeconomics. ... Introduction](https://reader031.vdocuments.us/reader031/viewer/2022030423/5aaab43b7f8b9a9a188e9069/html5/thumbnails/22.jpg)
Historical roots of the field :
In Europe
Development of the drug classification system ( WHO ATC/DDD ) system in the Nordic countries for wholesaler drug sales statistics from1969 (Euro-DURG).
In the US and Canada
Drug Utlization Review (Evaluation) in hospitals with the start of Clinical pharmacy (Brodie, 1972).
In the world
Movement to promote rational drug prescribing(INRUD – 1972)
![Page 23: Methodological Framework and Tools for Cross …users.ugent.be/~lvbortel/Sunday_10.pdfDefinition of drug utilization research and deliniation ... Pharmacoeconomics. ... Introduction](https://reader031.vdocuments.us/reader031/viewer/2022030423/5aaab43b7f8b9a9a188e9069/html5/thumbnails/23.jpg)
Drug utilization monitoring systems
Qualitative research
Prescribing quality indicators
Intervention research
FOUR FACES OF DRUG UTILIZATION RESEARCH
![Page 24: Methodological Framework and Tools for Cross …users.ugent.be/~lvbortel/Sunday_10.pdfDefinition of drug utilization research and deliniation ... Pharmacoeconomics. ... Introduction](https://reader031.vdocuments.us/reader031/viewer/2022030423/5aaab43b7f8b9a9a188e9069/html5/thumbnails/24.jpg)
THE MICRO LEVEL OF
DRUG UTILIZATION RESEARCH
Understanding
prescribing and drug taking behavior
![Page 25: Methodological Framework and Tools for Cross …users.ugent.be/~lvbortel/Sunday_10.pdfDefinition of drug utilization research and deliniation ... Pharmacoeconomics. ... Introduction](https://reader031.vdocuments.us/reader031/viewer/2022030423/5aaab43b7f8b9a9a188e9069/html5/thumbnails/25.jpg)
4000 products onthe national market
200 productsprescribedby 1 GP
4 Evoked set
The drug choice process of the physician
(Denig and Haaijer-Ruskamp)1 prescribed product
Clinicalproblem
![Page 26: Methodological Framework and Tools for Cross …users.ugent.be/~lvbortel/Sunday_10.pdfDefinition of drug utilization research and deliniation ... Pharmacoeconomics. ... Introduction](https://reader031.vdocuments.us/reader031/viewer/2022030423/5aaab43b7f8b9a9a188e9069/html5/thumbnails/26.jpg)
The drug choice process of the patient
To be aware of a problem
To go and see the doctor
To go and see the pharmacist
To accept and start the prescribed medicine
To continue the treatment
![Page 27: Methodological Framework and Tools for Cross …users.ugent.be/~lvbortel/Sunday_10.pdfDefinition of drug utilization research and deliniation ... Pharmacoeconomics. ... Introduction](https://reader031.vdocuments.us/reader031/viewer/2022030423/5aaab43b7f8b9a9a188e9069/html5/thumbnails/27.jpg)
BenefitRisk
time
Dosing events
Dynamical changes in risk/benefit ratio
![Page 28: Methodological Framework and Tools for Cross …users.ugent.be/~lvbortel/Sunday_10.pdfDefinition of drug utilization research and deliniation ... Pharmacoeconomics. ... Introduction](https://reader031.vdocuments.us/reader031/viewer/2022030423/5aaab43b7f8b9a9a188e9069/html5/thumbnails/28.jpg)
BenefitRisk
time
Dosing events
Dynamical changes in risk/benefit ratio
![Page 29: Methodological Framework and Tools for Cross …users.ugent.be/~lvbortel/Sunday_10.pdfDefinition of drug utilization research and deliniation ... Pharmacoeconomics. ... Introduction](https://reader031.vdocuments.us/reader031/viewer/2022030423/5aaab43b7f8b9a9a188e9069/html5/thumbnails/29.jpg)
THE MACRO LEVEL OF
DRUG UTILIZATION RESEARCH
Tools for cross-national comparison of
drug utilization
![Page 30: Methodological Framework and Tools for Cross …users.ugent.be/~lvbortel/Sunday_10.pdfDefinition of drug utilization research and deliniation ... Pharmacoeconomics. ... Introduction](https://reader031.vdocuments.us/reader031/viewer/2022030423/5aaab43b7f8b9a9a188e9069/html5/thumbnails/30.jpg)
Examples of methods used for
international (cross-national) drug utilization research
Health surveys
Cross sectional descriptive studies
Rapid assessment of health services
Qualitative studies
Disease register studies
Clinical Cohort studies
Database Cohort studies
Claims and prescription database studies
![Page 31: Methodological Framework and Tools for Cross …users.ugent.be/~lvbortel/Sunday_10.pdfDefinition of drug utilization research and deliniation ... Pharmacoeconomics. ... Introduction](https://reader031.vdocuments.us/reader031/viewer/2022030423/5aaab43b7f8b9a9a188e9069/html5/thumbnails/31.jpg)
FOCUS ON :
Cross-national studies,
aiming to compare overall drug utilization patterns
(of all medicines or of big classes of medicines)
of the entire population of the country
by collecting census data,
consistent over time
![Page 32: Methodological Framework and Tools for Cross …users.ugent.be/~lvbortel/Sunday_10.pdfDefinition of drug utilization research and deliniation ... Pharmacoeconomics. ... Introduction](https://reader031.vdocuments.us/reader031/viewer/2022030423/5aaab43b7f8b9a9a188e9069/html5/thumbnails/32.jpg)
Basic requirements of a minimal national data set
on Drug Utilization Data for cross-national comparisons
Comprehensive collection of drug consumption data
- from all citizens of the country
- from all medicines (legal definition ?)
Splitable into ambulatory care / hospital carePrescription / Over The CounterReimbursed / not reimbursed
Validly linked to ATC / DDD
In terms of quantity consumed and money spent
Consistent over time (decades)
In months, quarters and years
![Page 33: Methodological Framework and Tools for Cross …users.ugent.be/~lvbortel/Sunday_10.pdfDefinition of drug utilization research and deliniation ... Pharmacoeconomics. ... Introduction](https://reader031.vdocuments.us/reader031/viewer/2022030423/5aaab43b7f8b9a9a188e9069/html5/thumbnails/33.jpg)
Two illustrations :
1. European Surveilance of Antibiotic Consumption
(ESAC project)
2. Long term longitudinal national data from Belgium
![Page 34: Methodological Framework and Tools for Cross …users.ugent.be/~lvbortel/Sunday_10.pdfDefinition of drug utilization research and deliniation ... Pharmacoeconomics. ... Introduction](https://reader031.vdocuments.us/reader031/viewer/2022030423/5aaab43b7f8b9a9a188e9069/html5/thumbnails/34.jpg)
Illustration 1 :
The ESAC project
![Page 35: Methodological Framework and Tools for Cross …users.ugent.be/~lvbortel/Sunday_10.pdfDefinition of drug utilization research and deliniation ... Pharmacoeconomics. ... Introduction](https://reader031.vdocuments.us/reader031/viewer/2022030423/5aaab43b7f8b9a9a188e9069/html5/thumbnails/35.jpg)
Total outpatient antibiotic use in 26 European countries in 2002
(Lancet, ESAC, Goossens et al., 2005)
![Page 36: Methodological Framework and Tools for Cross …users.ugent.be/~lvbortel/Sunday_10.pdfDefinition of drug utilization research and deliniation ... Pharmacoeconomics. ... Introduction](https://reader031.vdocuments.us/reader031/viewer/2022030423/5aaab43b7f8b9a9a188e9069/html5/thumbnails/36.jpg)
Seasonal variation in antibiotic use (1997-2002)
(Goossens et al., Lancet, 2005)
![Page 37: Methodological Framework and Tools for Cross …users.ugent.be/~lvbortel/Sunday_10.pdfDefinition of drug utilization research and deliniation ... Pharmacoeconomics. ... Introduction](https://reader031.vdocuments.us/reader031/viewer/2022030423/5aaab43b7f8b9a9a188e9069/html5/thumbnails/37.jpg)
Need for methodological rigor
in cross-national drug utilization research
with administrative databases
(Vander Stichele et al., Brit J Clin Pharmacol, 2004)
![Page 38: Methodological Framework and Tools for Cross …users.ugent.be/~lvbortel/Sunday_10.pdfDefinition of drug utilization research and deliniation ... Pharmacoeconomics. ... Introduction](https://reader031.vdocuments.us/reader031/viewer/2022030423/5aaab43b7f8b9a9a188e9069/html5/thumbnails/38.jpg)
Checklist for evaluating the validity of the data
1. Problems with population coverage
2. Problems with drug coverage
3. Problems with ambulatory/hospital care mix
![Page 39: Methodological Framework and Tools for Cross …users.ugent.be/~lvbortel/Sunday_10.pdfDefinition of drug utilization research and deliniation ... Pharmacoeconomics. ... Introduction](https://reader031.vdocuments.us/reader031/viewer/2022030423/5aaab43b7f8b9a9a188e9069/html5/thumbnails/39.jpg)
Initial consumption data of Greece and Spain
Greece
Spain
![Page 40: Methodological Framework and Tools for Cross …users.ugent.be/~lvbortel/Sunday_10.pdfDefinition of drug utilization research and deliniation ... Pharmacoeconomics. ... Introduction](https://reader031.vdocuments.us/reader031/viewer/2022030423/5aaab43b7f8b9a9a188e9069/html5/thumbnails/40.jpg)
Suspected bias
Up to 10% overestimated due toparallel exports
exclusion of OTC sales
Up to 30% underestimated due to
![Page 41: Methodological Framework and Tools for Cross …users.ugent.be/~lvbortel/Sunday_10.pdfDefinition of drug utilization research and deliniation ... Pharmacoeconomics. ... Introduction](https://reader031.vdocuments.us/reader031/viewer/2022030423/5aaab43b7f8b9a9a188e9069/html5/thumbnails/41.jpg)
Corrected data after validity check
Greece
Spain
![Page 42: Methodological Framework and Tools for Cross …users.ugent.be/~lvbortel/Sunday_10.pdfDefinition of drug utilization research and deliniation ... Pharmacoeconomics. ... Introduction](https://reader031.vdocuments.us/reader031/viewer/2022030423/5aaab43b7f8b9a9a188e9069/html5/thumbnails/42.jpg)
Corrected data after validity check
Greece
Spain
![Page 43: Methodological Framework and Tools for Cross …users.ugent.be/~lvbortel/Sunday_10.pdfDefinition of drug utilization research and deliniation ... Pharmacoeconomics. ... Introduction](https://reader031.vdocuments.us/reader031/viewer/2022030423/5aaab43b7f8b9a9a188e9069/html5/thumbnails/43.jpg)
Problems with the link of the national drug code
to international
Anatomical Therapeutic Chemical Classification (ATC)
![Page 44: Methodological Framework and Tools for Cross …users.ugent.be/~lvbortel/Sunday_10.pdfDefinition of drug utilization research and deliniation ... Pharmacoeconomics. ... Introduction](https://reader031.vdocuments.us/reader031/viewer/2022030423/5aaab43b7f8b9a9a188e9069/html5/thumbnails/44.jpg)
Luxemburg
TOTAL ANTIBIOTIC USE IN AC
Others
Sulfonamides J01E
Quinolones J01M
Macrolides J01F
Tetracyclines J01A
Cephalosporins J01D
Penicillins J01C
J01B+J01G+J01R+J01X
ATC/DDD Classification Problems in ESAC project:Switch from G04 to J01MB, J01XE and J01XX:
consumption not recorded before 2000 in Luxemburg
![Page 45: Methodological Framework and Tools for Cross …users.ugent.be/~lvbortel/Sunday_10.pdfDefinition of drug utilization research and deliniation ... Pharmacoeconomics. ... Introduction](https://reader031.vdocuments.us/reader031/viewer/2022030423/5aaab43b7f8b9a9a188e9069/html5/thumbnails/45.jpg)
TOTAL ANTIBIOTIC USE IN AC
Others
Sulfonamides J01E
Quinolones J01M
Macrolides J01F
Tetracyclines J01A
Cephalosporins J01D
Penicillins J01C
J01B+J01G+J01R+J01X
Suspicion of misclassification bias
Luxemburg
![Page 46: Methodological Framework and Tools for Cross …users.ugent.be/~lvbortel/Sunday_10.pdfDefinition of drug utilization research and deliniation ... Pharmacoeconomics. ... Introduction](https://reader031.vdocuments.us/reader031/viewer/2022030423/5aaab43b7f8b9a9a188e9069/html5/thumbnails/46.jpg)
TOTAL ANTIBIOTIC USE IN AC
0
5
10
15
20
25
30
35
1997 1998 1999 2000 2001
Tota
l use
in D
ID
Others
Sulfonamides J01E
Quinolones J01M
Macrolides J01F
Tetracyclines J01A
Cephalosporins J01D
Penicillins J01C
J01B+J01G+J01R+J01X
Rectification of misclassification bias
Luxemburg
![Page 47: Methodological Framework and Tools for Cross …users.ugent.be/~lvbortel/Sunday_10.pdfDefinition of drug utilization research and deliniation ... Pharmacoeconomics. ... Introduction](https://reader031.vdocuments.us/reader031/viewer/2022030423/5aaab43b7f8b9a9a188e9069/html5/thumbnails/47.jpg)
Relationship between consumption and resistancein 19 European countries (2000)
![Page 48: Methodological Framework and Tools for Cross …users.ugent.be/~lvbortel/Sunday_10.pdfDefinition of drug utilization research and deliniation ... Pharmacoeconomics. ... Introduction](https://reader031.vdocuments.us/reader031/viewer/2022030423/5aaab43b7f8b9a9a188e9069/html5/thumbnails/48.jpg)
Illustration 2 :
Long term longitudinal national data from Belgium
Expenditures on drugs (1990 to 2005) in Belgium
Drug utilization (2000-2005) in Belgium
![Page 49: Methodological Framework and Tools for Cross …users.ugent.be/~lvbortel/Sunday_10.pdfDefinition of drug utilization research and deliniation ... Pharmacoeconomics. ... Introduction](https://reader031.vdocuments.us/reader031/viewer/2022030423/5aaab43b7f8b9a9a188e9069/html5/thumbnails/49.jpg)
1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 20050
50
100
150
200
250
300
350
400
450
500
Fig.2: 15 years of pharmaceutical annual per capita expenditures in Belgium (in constant EUR 2005)
Co-payment Amb. Reimb. Specialties+magistralen
Other private expenditures Public expenditures
EUR/year/person
1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 20050
50
100
150
200
250
300
350
400
450
500
Fig.2: 15 years of pharmaceutical annual per capita expenditures in Belgium (in constant EUR 2005)
Co-payment Amb. Reimb. Specialties+magistralen
Other private expenditures Public expenditures
Longitudinal trends in pharmaceutical expenditures
in Belgium (1990 – 2005)
(Acta Clinica Belgica, Vander Stichele et al., 2003)
![Page 50: Methodological Framework and Tools for Cross …users.ugent.be/~lvbortel/Sunday_10.pdfDefinition of drug utilization research and deliniation ... Pharmacoeconomics. ... Introduction](https://reader031.vdocuments.us/reader031/viewer/2022030423/5aaab43b7f8b9a9a188e9069/html5/thumbnails/50.jpg)
0
1000
2000
3000
4000
5000
6000
7000
8000
Mill
ions
of D
DD
Not REMB HOSP REMB HOSP Not REIMB AMB REIM AMB2000 2001 2002 2003 2004 2005
Longitudinal trends in drug consumption in Belgium(2000-2005) (10.4 Million inhabitants)
![Page 51: Methodological Framework and Tools for Cross …users.ugent.be/~lvbortel/Sunday_10.pdfDefinition of drug utilization research and deliniation ... Pharmacoeconomics. ... Introduction](https://reader031.vdocuments.us/reader031/viewer/2022030423/5aaab43b7f8b9a9a188e9069/html5/thumbnails/51.jpg)
Kymograph print ?
![Page 52: Methodological Framework and Tools for Cross …users.ugent.be/~lvbortel/Sunday_10.pdfDefinition of drug utilization research and deliniation ... Pharmacoeconomics. ... Introduction](https://reader031.vdocuments.us/reader031/viewer/2022030423/5aaab43b7f8b9a9a188e9069/html5/thumbnails/52.jpg)
2004 2005
DDDs
Evolution of consumption of
drugs for peptic ulcer disease
in Belgium
between 2003 and 2006
![Page 53: Methodological Framework and Tools for Cross …users.ugent.be/~lvbortel/Sunday_10.pdfDefinition of drug utilization research and deliniation ... Pharmacoeconomics. ... Introduction](https://reader031.vdocuments.us/reader031/viewer/2022030423/5aaab43b7f8b9a9a188e9069/html5/thumbnails/53.jpg)
2004 2005
DDDs
Impact of restrictions
of reimbursement
and of the publication
of an evidence report
Van Driel et al., 2007
![Page 54: Methodological Framework and Tools for Cross …users.ugent.be/~lvbortel/Sunday_10.pdfDefinition of drug utilization research and deliniation ... Pharmacoeconomics. ... Introduction](https://reader031.vdocuments.us/reader031/viewer/2022030423/5aaab43b7f8b9a9a188e9069/html5/thumbnails/54.jpg)
2004 2005
DDDs
Application of
time series analysis
![Page 55: Methodological Framework and Tools for Cross …users.ugent.be/~lvbortel/Sunday_10.pdfDefinition of drug utilization research and deliniation ... Pharmacoeconomics. ... Introduction](https://reader031.vdocuments.us/reader031/viewer/2022030423/5aaab43b7f8b9a9a188e9069/html5/thumbnails/55.jpg)
IN CONCLUSION:
• Drug utilization research is part of pharmaco-epidemiology and clinical pharmacology
• Consumption of drugs must be studied both at the micro level and at the macro level.
• It is an eclectic discipline both in content and in methodology.